Subcutan heparin-calcium kezelés

klinikai és laboratóriumi tapasztalatok.

Translated title of the contribution: Subcutaneous heparin-calcium therapy: clinical and laboratory experience

Z. Boda, K. Rák

Research output: Contribution to journalArticle

Abstract

Fifty patients with acute deep vein thrombosis, pulmonary embolism, acute myocardial infarct and priapism were treated with subcutaneous calcium heparin. Laboratory control was based on the examination of APTT. On the first day of heparin therapy only 52% of patients's APTT was 1.5 times greater than control value but the ratio increased to 82% on the fifth day of treatment. The importance of initial venous sodium heparin bolus (5-10,000 U) followed immediately by subcutaneous calcium heparin is emphasized. Injection of 500 U/kg/day calcium heparin divided in two equal doses is recommended. Four thrombotic and two haemorrhagic complications were observed. Subcutaneous calcium heparin can substitute the intravenous form of heparin (either bolus or continuous) in the treatment of thromboembolism.

Original languageHungarian
Pages (from-to)2347-2349
Number of pages3
JournalOrvosi Hetilap
Volume130
Issue number44
Publication statusPublished - Oct 29 1989

Fingerprint

Heparin
Priapism
Thromboembolism
Therapeutics
Pulmonary Embolism
Venous Thrombosis
Myocardial Infarction
Injections
calcium heparin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Subcutan heparin-calcium kezelés : klinikai és laboratóriumi tapasztalatok. / Boda, Z.; Rák, K.

In: Orvosi Hetilap, Vol. 130, No. 44, 29.10.1989, p. 2347-2349.

Research output: Contribution to journalArticle

@article{7ba294cec2154931a887aa73bf27e493,
title = "Subcutan heparin-calcium kezel{\'e}s: klinikai {\'e}s laborat{\'o}riumi tapasztalatok.",
abstract = "Fifty patients with acute deep vein thrombosis, pulmonary embolism, acute myocardial infarct and priapism were treated with subcutaneous calcium heparin. Laboratory control was based on the examination of APTT. On the first day of heparin therapy only 52{\%} of patients's APTT was 1.5 times greater than control value but the ratio increased to 82{\%} on the fifth day of treatment. The importance of initial venous sodium heparin bolus (5-10,000 U) followed immediately by subcutaneous calcium heparin is emphasized. Injection of 500 U/kg/day calcium heparin divided in two equal doses is recommended. Four thrombotic and two haemorrhagic complications were observed. Subcutaneous calcium heparin can substitute the intravenous form of heparin (either bolus or continuous) in the treatment of thromboembolism.",
author = "Z. Boda and K. R{\'a}k",
year = "1989",
month = "10",
day = "29",
language = "Hungarian",
volume = "130",
pages = "2347--2349",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "44",

}

TY - JOUR

T1 - Subcutan heparin-calcium kezelés

T2 - klinikai és laboratóriumi tapasztalatok.

AU - Boda, Z.

AU - Rák, K.

PY - 1989/10/29

Y1 - 1989/10/29

N2 - Fifty patients with acute deep vein thrombosis, pulmonary embolism, acute myocardial infarct and priapism were treated with subcutaneous calcium heparin. Laboratory control was based on the examination of APTT. On the first day of heparin therapy only 52% of patients's APTT was 1.5 times greater than control value but the ratio increased to 82% on the fifth day of treatment. The importance of initial venous sodium heparin bolus (5-10,000 U) followed immediately by subcutaneous calcium heparin is emphasized. Injection of 500 U/kg/day calcium heparin divided in two equal doses is recommended. Four thrombotic and two haemorrhagic complications were observed. Subcutaneous calcium heparin can substitute the intravenous form of heparin (either bolus or continuous) in the treatment of thromboembolism.

AB - Fifty patients with acute deep vein thrombosis, pulmonary embolism, acute myocardial infarct and priapism were treated with subcutaneous calcium heparin. Laboratory control was based on the examination of APTT. On the first day of heparin therapy only 52% of patients's APTT was 1.5 times greater than control value but the ratio increased to 82% on the fifth day of treatment. The importance of initial venous sodium heparin bolus (5-10,000 U) followed immediately by subcutaneous calcium heparin is emphasized. Injection of 500 U/kg/day calcium heparin divided in two equal doses is recommended. Four thrombotic and two haemorrhagic complications were observed. Subcutaneous calcium heparin can substitute the intravenous form of heparin (either bolus or continuous) in the treatment of thromboembolism.

UR - http://www.scopus.com/inward/record.url?scp=0024980806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024980806&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 2347

EP - 2349

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 44

ER -